1. Home >
  2. M&A >
  3. Divestiture >
  4. United States >
  5. Minnesota >
  6. DeRoyal Industries Acquires Skyline Medical

M&A Deal Summary

DeRoyal Industries Acquires Skyline Medical

On March 20, 2025, DeRoyal Industries acquired medical products company Skyline Medical from Predictive Oncology

Acquisition Highlights
  • This is DeRoyal Industries’ 1st transaction in the Medical Products sector.
  • This is DeRoyal Industries’ 1st transaction in the United States.
  • This is DeRoyal Industries’ 1st transaction in Minnesota.

M&A Deal Summary
Date 2025-03-20
Target Skyline Medical
Sector Medical Products
Buyer(s) DeRoyal Industries
Sellers(s) Predictive Oncology
Deal Type Divestiture

Target

Skyline Medical

St Paul, Minnesota, United States
Skyline Medical markets and sells the FDA-cleared STREAMWAY® System, a direct-to-drain wall suction waste fluid management technology that provides healthcare professionals with an automated, secure, and reliable method for managing potentially hazardous fluids, such as those generated during surgeries or other medical procedures. Skyline Medical was founded in 2002 and is based in St Paul, Minnesota.

Search 205,176 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

DeRoyal Industries

Powell, Tennessee, United States
Category Company
Founded 1973
Sector Manufacturing
Employees1,900
DESCRIPTION

DeRoyal Industries is a manufacturer and supplier of innovative healthcare products and services. The Company provides high-quality solutions that improve patient outcomes, enhance the efficiency of healthcare providers, and support the success of healthcare facilities worldwide. The company offers a wide range of products including surgical, wound care, infection prevention, and waste management solutions. DeRoyal Industries was formed in 1973 and is headquartered in Powell, Tennessee.

DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Divestiture) 1 of 1
State (Minnesota) 1 of 1
Country (United States) 1 of 1
Year (2025) 1 of 1

Seller(S) 1

SELLER

Predictive Oncology

Eagan, Minnesota, United States
Category Company
Founded 2002
Sector Life Science
Employees34
Revenue 2M USD (2023)
DESCRIPTION

Predictive Oncology operates through three segments (Domestic, International, and other), which contain four subsidiaries; Helomics, TumorGenesis, Skyline Medical, and Skyline Europe. Predictive Oncology was founded in 2002 and is based in Eagan, Minnesota.

DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Divestiture) 1 of 1
State (Minnesota) 1 of 1
Country (United States) 1 of 1
Year (2025) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-12-01 zPREDICTA

San Jose, California, United States

zPREDICTA develops tumor-specific in vitro models for oncology drug discovery and research. Its mission is to accelerate the drug development process for pharmaceutical clients and partners. Based on their proprietary models, zPREDICTA offers preclinical testing services to clients in the biopharmaceutical industry and through its partnership with a large pharma company. zPREDICTA was founded in 2014 and is based in San Jose, California.

Buy -
Mergr

Product

Company

Legal